long-term effects of glp-1 drugs long term GLP-1 medications, commonly used for type 2 diabetes GLP-1 Medications for Weight Loss:

pharmaceutical landscape, GLP-1 medications have surged to blockbuster status, driven by soaring demand for both diabetes management and weight loss solutions

The WHO further notes that obesity significantly increases the risk of cardiovascular disease, stroke and type 2 diabetes, while additional research has linked excess weight to chronic kidney disease and rising healthcare expenditures, creating substantial pressure on healthcare systems globally

Berning P, Adhikari R, Schroer AE, Jelwan YA, Razavi AC, Blaha MJ, et al

Retatrutide: still in clinical trials Retatrutide has not received FDA approval for any indication

Only helpful for stool in the rectum

doi: 10.1002/psc.861 35 GallwitzBWittMFlschURCreutzfeldtWSchmidtWE